Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study. Schettini F, Blondeaux E, Molinelli C, Bas R, et al. Cancer 2024 May 16. doi: 10.1002/cncr.35323.

Read + Share

Amedeo Smart

Independent Medical Education